Details for New Drug Application (NDA): 077917
✉ Email this page to a colleague
The generic ingredient in PRAVASTATIN SODIUM is pravastatin sodium. There are sixteen drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the pravastatin sodium profile page.
Summary for 077917
| Tradename: | PRAVASTATIN SODIUM |
| Applicant: | Chartwell Rx |
| Ingredient: | pravastatin sodium |
| Patents: | 0 |
Pharmacology for NDA: 077917
| Mechanism of Action | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
Medical Subject Heading (MeSH) Categories for 077917
Suppliers and Packaging for NDA: 077917
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 077917 | ANDA | Chartwell RX, LLC | 62135-847 | 62135-847-90 | 90 TABLET, FILM COATED in 1 BOTTLE (62135-847-90) |
| PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 077917 | ANDA | Chartwell RX, LLC | 62135-848 | 62135-848-90 | 90 TABLET, FILM COATED in 1 BOTTLE (62135-848-90) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Jan 8, 2008 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
| Approval Date: | Jan 8, 2008 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 40MG | ||||
| Approval Date: | Jan 8, 2008 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
